Group leader
El equipo de investigadores del Instituto de Bioingeniería de Cataluña (IBEC) liderado por Óscar Castaño, han desarrollado andamios de PLA-CaP que mejoran la cicatrización y regeneración del tejido óseo. Estos … Read more
Critical bone defects resulting from trauma, tumor resection, or congenital conditions present significant challenges in medical treatment due to high rates of graft failure caused by inadequate blood supply. To address this issue, researchers at the Institute for Bioengineering of Catalonia have developed novel 3D printed scaffolds made from polylactic acid and calcium phosphate. These innovative scaffolds promote blood vessel formation, ensuring better healing and regeneration of bone tissue.
The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.
The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.
The latest developments in nanotechnology, biotechnology and medicine were presented at the NanoBio&Med 2024 International Conference, held this week at the Barcelona Science Park (PCB) from 5 to 7 November. This is an annual event designed to establish new collaborations and promote innovative projects in the scientific-industrial sector.
Bioaction is an EU-funded project, in which IBEC is involved, that aims to revolutionize the approach to implant-associated infections. By harnessing hydrogels and smart nanomaterials, Bioaction will transform bacterial biofilms into bio-factories for tissue regeneration, offering a novel alternative to traditional antibiotic therapies. The project is driven by a multidisciplinary team of experts and strives to improve patient outcomes while addressing the global challenge of antimicrobial resistance.
IBEC researchers Elisabeth Engel and Gabriel Gomila have been awarded the “ICREA Acadèmia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). Engel and Gomila, who lead their … Read more
During the visit, the President of the Government of Catalonia, Pere Aragonès i Garcia, and the Minister of Health, Manel Balcells i Díaz, were able to learn first-hand about several … Read more
Lead researcher Eli Engel and IBEC researcher Bárbara Blanco are featured on RTVE for their recent research against breast cancer. Using 3D bioprinting they have created tumors from pig tissue. … Read more
